Kai‐Chen Wu

597 total citations
18 papers, 449 citations indexed

About

Kai‐Chen Wu is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Kai‐Chen Wu has authored 18 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Organic Chemistry. Recurrent topics in Kai‐Chen Wu's work include Histone Deacetylase Inhibitors Research (5 papers), Complement system in diseases (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Kai‐Chen Wu is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Complement system in diseases (4 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Kai‐Chen Wu collaborates with scholars based in Australia, Greece and Cyprus. Kai‐Chen Wu's co-authors include Jianwei Du, David P. Fairlie, Junxian Lim, Jacky Y. Suen, Yuhong Jiang, Weijun Xu, Mei‐Kwan Yau, Robert C. Reid, Aline D. de Araujo and Andrew C. Good and has published in prestigious journals such as Nature Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Kai‐Chen Wu

18 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai‐Chen Wu Australia 11 197 107 66 64 62 18 449
Gil Arvatz Israel 11 513 2.6× 42 0.4× 42 0.6× 66 1.0× 88 1.4× 14 752
Huiling Han United States 10 362 1.8× 30 0.3× 68 1.0× 66 1.0× 35 0.6× 18 574
Anita J. Horvath Australia 13 246 1.2× 33 0.3× 174 2.6× 189 3.0× 19 0.3× 17 713
M. R. Grever United States 8 112 0.6× 52 0.5× 28 0.4× 29 0.5× 29 0.5× 20 343
Mário Costa Cruz Brazil 13 242 1.2× 132 1.2× 8 0.1× 98 1.5× 17 0.3× 38 526
E Nègre United States 9 295 1.5× 34 0.3× 48 0.7× 53 0.8× 26 0.4× 12 472
Adam C. Mirando United States 16 415 2.1× 33 0.3× 17 0.3× 70 1.1× 17 0.3× 23 636
Sudong Zhang China 6 179 0.9× 21 0.2× 42 0.6× 388 6.1× 54 0.9× 11 597
A. Pennings Netherlands 12 215 1.1× 57 0.5× 179 2.7× 65 1.0× 18 0.3× 25 452
Yael S. Schiffenbauer Israel 10 170 0.9× 72 0.7× 17 0.3× 108 1.7× 10 0.2× 24 489

Countries citing papers authored by Kai‐Chen Wu

Since Specialization
Citations

This map shows the geographic impact of Kai‐Chen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Chen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Chen Wu more than expected).

Fields of papers citing papers by Kai‐Chen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Chen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Chen Wu. The network helps show where Kai‐Chen Wu may publish in the future.

Co-authorship network of co-authors of Kai‐Chen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Chen Wu. A scholar is included among the top collaborators of Kai‐Chen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Chen Wu. Kai‐Chen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Ligong, Kai‐Chen Wu, Junxian Lim, et al.. (2024). A novel inhibitor of class IIa histone deacetylases attenuates collagen‐induced arthritis. British Journal of Pharmacology. 181(23). 4804–4821. 1 indexed citations
2.
Wu, Kai‐Chen, Nicholas D. Condon, Timothy A. Hill, et al.. (2023). Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages. Journal of Innate Immunity. 15(1). 468–484. 8 indexed citations
3.
Mantzourani, Christiana, Kai‐Chen Wu, Huy N. Hoang, et al.. (2023). N-(2-Aminophenyl)-benzamide Inhibitors of Class I HDAC Enzymes with Antiproliferative and Antifibrotic Activity. Journal of Medicinal Chemistry. 66(20). 14357–14376. 7 indexed citations
4.
Araujo, Aline D. de, Junxian Lim, Kai‐Chen Wu, et al.. (2022). Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake. RSC Chemical Biology. 3(7). 895–904. 16 indexed citations
5.
Mak, Jeffrey Y. W., Kai‐Chen Wu, Praveer Gupta, et al.. (2021). HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates. Journal of Medicinal Chemistry. 64(4). 2186–2204. 19 indexed citations
6.
Mantzourani, Christiana, Alexandros C. Kokotos, Pirjo Nummela, et al.. (2021). Synthesis of benzoxazole-based vorinostat analogs and their antiproliferative activity. Bioorganic Chemistry. 114. 105132–105132. 9 indexed citations
7.
Lim, Junxian, Kai‐Chen Wu, Andrew J. Lucke, et al.. (2020). Achiral Derivatives of Hydroxamate AR-42 Potently Inhibit Class I HDAC Enzymes and Cancer Cell Proliferation. Journal of Medicinal Chemistry. 63(11). 5956–5971. 22 indexed citations
8.
Rowley, Jessica A., Robert C. Reid, Kai‐Chen Wu, et al.. (2020). Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity. Journal of Medicinal Chemistry. 63(2). 529–541. 21 indexed citations
9.
Jiang, Yuhong, Junxian Lim, Kai‐Chen Wu, et al.. (2020). PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR. British Journal of Pharmacology. 178(4). 913–932. 29 indexed citations
10.
Araujo, Aline D. de, Junxian Lim, Kai‐Chen Wu, et al.. (2018). Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins. Journal of Medicinal Chemistry. 61(7). 2962–2972. 47 indexed citations
11.
Lohman, Rink‐Jan, Robert C. Reid, Jessica A. Rowley, et al.. (2017). Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a. Nature Communications. 8(1). 33 indexed citations
12.
Jiang, Yuhong, Mei‐Kwan Yau, Junxian Lim, et al.. (2017). A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells. Journal of Pharmacology and Experimental Therapeutics. 364(2). 246–257. 48 indexed citations
13.
Jiang, Yuhong, Mei‐Kwan Yau, W. Mei Kok, et al.. (2017). Biased Signaling by Agonists of Protease Activated Receptor 2. ACS Chemical Biology. 12(5). 1217–1226. 34 indexed citations
14.
Araujo, Aline D. de, Chongyang Wu, Kai‐Chen Wu, et al.. (2017). Europium-Labeled Synthetic C3a Protein as a Novel Fluorescent Probe for Human Complement C3a Receptor. Bioconjugate Chemistry. 28(6). 1669–1676. 9 indexed citations
15.
Xu, Weijun, Junxian Lim, Jacky Y. Suen, et al.. (2015). Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2. Journal of Chemical Information and Modeling. 55(10). 2079–2084. 8 indexed citations
16.
Du, Jianwei & Kai‐Chen Wu. (2010). Global malaria control and elimination: report of a technical review.. Zhongguo redai yixue. 10(7). 821–823. 97 indexed citations
17.
Wu, Kai‐Chen, et al.. (2010). Differential effect of ECM molecules on re‐expression of cartilaginous markers in near quiescent human chondrocytes. Journal of Cellular Physiology. 226(8). 1981–1988. 37 indexed citations
18.
Wu, Kai‐Chen. (2005). [Mathematical model in prediction and evaluation of the effects on control measures for schistosomiasis].. PubMed. 23(6). 408–14. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gil Arvatz Breakdown of academic impact, for papers by Huiling Han Breakdown of academic impact, for papers by Anita J. Horvath Breakdown of academic impact, for papers by M. R. Grever Breakdown of academic impact, for papers by Mário Costa Cruz Breakdown of academic impact, for papers by E Nègre Breakdown of academic impact, for papers by Adam C. Mirando Breakdown of academic impact, for papers by Sudong Zhang Breakdown of academic impact, for papers by A. Pennings Breakdown of academic impact, for papers by Yael S. Schiffenbauer
Rankless by CCL
2026